◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

VIEMED HEALTHCARE, INC.

CIK: 1729149 SIC: 8090
$270.28M
Revenue
$14.93M
Net Income
57.52%
Gross Margin
8.49%
Op. Margin
$-9.20M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 20 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $76.18M $71.91M $63.06M $59.13M $60.70M $58.00M $54.97M
Revenue Growth % (YoY) 25.5% 24.0% 14.7% nan% nan% nan% nan%
Cost of Revenue $32.08M $30.57M $26.32M $25.85M $24.56M $23.63M $22.07M
+ Gross Profit $44.10M $41.34M $36.73M $33.28M $36.14M $34.37M $32.89M
Gross Margin % 57.9% 57.5% 58.3% 56.3% 59.5% 59.3% 59.8%
Research & Development $598.00K $775.00K $847.00K $797.00K $803.00K $757.00K $758.00K
Selling General & Admin $32.22M $31.92M $28.80M $28.43M $28.21M $26.67M $26.50M
+ Operating Income $8.37M $5.64M $5.09M $3.84M $6.45M $5.63M $3.62M
Operating Margin % 11.0% 7.8% 8.1% 6.5% 10.6% 9.7% 6.6%
Interest Expense $287.00K $587.00K $212.00K $125.00K $205.00K $745.00K $515.00K
Other Income/Expense $61.00K $44.00K $72.00K $75.00K $88.00K $276.00K $-563.00K
Income Before Tax $8.01M $5.13M $4.96M $3.66M $6.30M $5.50M $2.25M
Income Tax Expense $2.19M $1.53M $1.71M $952.00K $1.88M $1.59M $768.00K
+ Net Income $5.64M $3.51M $3.16M $2.62M $4.32M $3.88M $1.47M
Net Margin % 7.4% 4.9% 5.0% 4.4% 7.1% 6.7% 2.7%
Basic EPS nan 0.09 0.08 0.07 0.11 0.10 0.04
Diluted EPS nan 0.09 0.08 0.06 0.11 0.10 0.04
Basic Shares Outstanding -295K 38.6M 39.5M 39.4M -49K 38.9M 38.8M
Diluted Shares Outstanding -262K 40.5M 41.1M 41.6M 103K 40.8M 40.6M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $13.50M $11.12M $20.02M $10.16M $17.54M $11.35M $8.81M
Accounts Receivable $25.59M $27.41M $26.55M $26.79M $24.91M $27.05M $27.06M
Inventory $5.05M $5.27M $4.32M $4.51M $4.32M $4.31M $4.42M
Other Current Assets $4.13M $4.26M $4.40M $7.66M $6.11M $4.99M $4.24M
Total Current Assets $48.49M $49.98M $55.29M $49.12M $52.88M $47.70M $44.98M
Property Plant & Equipment $78.78M $80.51M $79.73M $81.05M $76.28M $74.40M $74.70M
Goodwill $58.94M $58.46M $32.99M $32.99M $32.99M $32.99M $32.99M
Intangible Assets $1.28M $1.35M $783.00K $816.00K $848.00K $880.00K $912.00K
Other Non-current Assets - - - - - - -
Total Assets $199.15M $202.36M $184.60M $178.08M $177.07M $169.53M $163.95M
Accrued Liabilities $23.91M $25.01M $18.64M $17.54M $20.16M $19.92M $16.80M
Deferred Revenue $7.52M $7.81M $7.19M $6.79M $6.69M $6.82M $6.72M
Total Current Liabilities $41.06M $44.19M $37.27M $35.49M $37.33M $36.44M $31.48M
Long-term Debt $11.29M $19.59M $3.46M $3.53M $3.59M $3.65M $8.71M
Total Liabilities $55.63M $66.86M $42.98M $41.33M $43.77M $42.73M $42.77M
Common Stock $16.91M $16.90M $27.79M $28.15M $23.36M $22.75M $21.91M
Retained Earnings $102.89M $97.25M $93.84M $90.73M $89.69M $85.38M $81.59M
Total Stockholders Equity $141.54M $133.61M $139.73M $134.76M $131.39M $124.96M $119.37M
Total Liabilities & Equity $199.15M $202.36M $184.60M $178.08M $177.07M $169.53M $163.95M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $5.64M $3.51M $5.78M $2.62M $4.32M $6.95M $1.47M
Depreciation & Amortization $7.57M $21.04M $13.50M $6.61M $6.37M $19.00M $12.59M
Stock-based Compensation $2.30M $6.83M $4.65M $2.31M $1.52M $4.76M $3.05M
Deferred Income Tax $380.00K $2.73M $-1.96M - $-333.00K $-3.51M -
Change in Receivables $-1.83M $670.00K $1.64M $1.88M $-2.14M $8.21M $8.22M
Change in Inventory $-222.00K $163.00K $4.00K $190.00K $9.00K $-583.00K $-470.00K
Operating Cash Flow $18.44M $33.48M $15.11M $2.85M $14.99M $24.10M $11.36M
Capital Expenditure $8.74M $31.25M $23.61M $15.48M $11.83M $25.94M $14.94M
Acquisitions - $26.33M - - - $3.00M $3.00M
Investing Cash Flow $-7.61M $-42.55M $-10.26M $-8.53M $-9.20M $-21.50M $-16.53M
Stock Repurchased - $13.22M $1.66M - - - -
Financing Cash Flow $-8.45M $2.66M $-2.38M $-1.70M $404.00K $-4.09M $1.14M
Net Change in Cash $2.38M $-6.42M $2.48M $-7.38M $6.19M $-1.49M $-4.03M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $71.91M - $194.10M -
Cost of Revenue $30.57M - $82.74M -
Gross Profit $41.34M - $111.36M -
Research & Development $775.00K - $2.42M -
Selling General & Admin $31.92M - $89.15M -
Operating Income $5.64M - $14.58M -
Interest Expense - - $587.00K -
Other Income/Expense $44.00K - $191.00K -
Income Before Tax $5.13M - $13.76M -
Income Tax Expense $1.53M - $4.20M -
Net Income $3.51M $1.48M $9.29M -
Basic EPS 0.09 - 0.24 -
Diluted EPS 0.09 - 0.23 -
Basic Shares Outstanding $38.64M - $39.19M -
Diluted Shares Outstanding $40.50M - $41.09M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $11.12M $17.54M
Accounts Receivable $27.41M $24.91M
Inventory $5.27M $4.32M
Other Current Assets $4.26M $6.11M
Total Current Assets $49.98M $52.88M
Property Plant & Equipment $80.51M $76.28M
Goodwill $58.46M $32.99M
Intangible Assets $1.35M $848.00K
Total Assets $202.36M $177.07M
Accrued Liabilities $25.01M $20.16M
Deferred Revenue $7.81M $6.69M
Total Current Liabilities $44.19M $37.33M
Long-term Debt $19.59M $3.59M
Total Liabilities $66.86M $43.77M
Common Stock $16.90M $23.36M
Retained Earnings $97.25M $89.69M
Total Stockholders Equity $133.61M $131.39M
Total Liabilities & Equity $202.36M $177.07M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $3.51M $1.48M $9.29M -
Depreciation & Amortization $397.00K - $21.04M -
Stock-based Compensation - - $6.83M -
Deferred Income Tax - - $2.73M -
Change in Receivables - - $670.00K -
Change in Inventory - - $163.00K -
Operating Cash Flow - - $33.48M -
Capital Expenditure - - $31.25M -
Acquisitions - - $26.33M -
Investing Cash Flow - - $-42.55M -
Stock Repurchased - - $13.22M -
Financing Cash Flow - - $2.66M -
Net Change in Cash - - $-6.42M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...